Literature DB >> 23478422

PedsQL eosinophilic esophagitis module: feasibility, reliability, and validity.

James P Franciosi1, Kevin A Hommel, Cristiane B Bendo, Eileen C King, Margaret H Collins, Michael D Eby, Keith Marsolo, J Pablo Abonia, Karl F von Tiehl, Philip E Putnam, Alexandria J Greenler, Allison B Greenberg, Ronald A Bryson, Carla M Davis, Anthony P Olive, Sandeep K Gupta, Elizabeth A Erwin, Mary D Klinnert, Jonathan M Spergel, Jolanda M Denham, Glenn T Furuta, Marc E Rothenberg, James W Varni.   

Abstract

OBJECTIVE: Eosinophilic esophagitis (EoE) is a chronic esophageal inflammatory condition with a paucity of information on health-related quality of life (HRQOL). The objective of the study was to report on the measurement properties of the PedsQL EoE Module.
METHODS: The PedsQL EoE Module was completed in a multisite study by 196 pediatric patients with EoE and 262 parents of patients with EoE.
RESULTS: The PedsQL EoE Module scales evidenced excellent feasibility (0.6%-3.1% missing), excellent group comparison reliability across total scale scores (patient α 0.93; parent proxy α 0.94), good reliability for the 7 individual scales (patient α 0.75-0.87; parent proxy α 0.81-0.92), excellent test-retest reliability (patient intraclass correlation coefficient 0.88; parent intraclass correlation coefficient 0.82), demonstrated no floor effects and low ceiling effects, and demonstrated a high percentage of scaling success for most scales. Intercorrelations with the PedsQL Generic Core Scales were in the medium (0.30) to large (0.50) range. PedsQL EoE Module scores were worse among patients with active histologic disease (≥ 5 eos/hpf) compared with those in remission (patient self-report: 63.3 vs 69.9 [P < 0.05]; parent proxy report: 65.1 vs 72.3 [P < 0.01]), and those treated with dietary restrictions compared with those with no restrictions (patient self-report: 61.6 vs 74.3 [P < 0.01]; parent proxy report: 65.5 vs 74.7 [P < 0.01]).
CONCLUSIONS: The results demonstrate excellent measurement properties of the PedsQL EoE Module. Patients with active histologic disease and those treated with dietary restrictions demonstrated worse PedsQL scores. The PedsQL EoE Module may be used in the evaluation of pediatric EoE disease-specific HRQOL in clinical research and practice.

Entities:  

Mesh:

Year:  2013        PMID: 23478422      PMCID: PMC4115583          DOI: 10.1097/MPG.0b013e31828f1fd2

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  36 in total

1.  Pediatric health-related quality of life: Feasibility, reliability and validity of the PedsQL transplant module.

Authors:  J Weissberg-Benchell; T E Zielinski; S Rodgers; R N Greenley; D Askenazi; S L Goldstein; E M Fredericks; S McDiarmid; L Williams; C A Limbers; K Tuzinkiewicz; S Lerret; E M Alonso; J W Varni
Journal:  Am J Transplant       Date:  2010-07       Impact factor: 8.086

2.  The PedsQL in pediatric patients with Spinal Muscular Atrophy: feasibility, reliability, and validity of the Pediatric Quality of Life Inventory Generic Core Scales and Neuromuscular Module.

Authors:  Susan T Iannaccone; Linda S Hynan; Anne Morton; Renee Buchanan; Christine A Limbers; James W Varni
Journal:  Neuromuscul Disord       Date:  2009-10-28       Impact factor: 4.296

3.  PROMIS Pediatric Pain Interference Scale: an item response theory analysis of the pediatric pain item bank.

Authors:  James W Varni; Brian D Stucky; David Thissen; Esi Morgan Dewitt; Debra E Irwin; Jin-Shei Lai; Karin Yeatts; Darren A Dewalt
Journal:  J Pain       Date:  2010-06-02       Impact factor: 5.820

4.  An item response analysis of the pediatric PROMIS anxiety and depressive symptoms scales.

Authors:  Debra E Irwin; Brian Stucky; Michelle M Langer; David Thissen; Esi Morgan Dewitt; Jin-Shei Lai; James W Varni; Karin Yeatts; Darren A DeWalt
Journal:  Qual Life Res       Date:  2010-03-07       Impact factor: 4.147

5.  Construction of the Pediatric Asthma Impact Scale (PAIS) for the Patient-Reported Outcomes Measurement Information System (PROMIS).

Authors:  Karin B Yeatts; Brian Stucky; David Thissen; Deb Irwin; James W Varni; Esi Morgan DeWitt; Jin-Shei Lai; Darren A DeWalt
Journal:  J Asthma       Date:  2010-04       Impact factor: 2.515

6.  Health-related quality of life across pediatric chronic conditions.

Authors:  Lisa M Ingerski; Avani C Modi; Korey K Hood; Ahna L Pai; Meg Zeller; Carrie Piazza-Waggoner; Kimberly A Driscoll; Marc E Rothenberg; James Franciosi; Kevin A Hommel
Journal:  J Pediatr       Date:  2010-02-01       Impact factor: 4.406

7.  Sampling plan and patient characteristics of the PROMIS pediatrics large-scale survey.

Authors:  Debra E Irwin; Brian D Stucky; David Thissen; Esi Morgan Dewitt; Jin Shei Lai; Karin Yeatts; James W Varni; Darren A DeWalt
Journal:  Qual Life Res       Date:  2010-03-05       Impact factor: 4.147

Review 8.  Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment.

Authors:  Glenn T Furuta; Chris A Liacouras; Margaret H Collins; Sandeep K Gupta; Chris Justinich; Phil E Putnam; Peter Bonis; Eric Hassall; Alex Straumann; Marc E Rothenberg
Journal:  Gastroenterology       Date:  2007-08-08       Impact factor: 22.682

9.  The Mayo Dysphagia Questionnaire-30: documentation of reliability and validity of a tool for interventional trials in adults with esophageal disease.

Authors:  Judith McElhiney; Matthew R Lohse; Amindra S Arora; Joanna M Peloquin; Debra M Geno; Melissa M Kuntz; Felicity B Enders; Mary Fredericksen; Adil A Abdalla; Yulia Khan; Nicholas J Talley; Nancy N Diehl; Timothy J Beebe; Ann M Harris; Gianrico Farrugia; Darlene E Graner; Joseph A Murray; G Richard Locke; Rayna M Grothe; Michael D Crowell; Dawn L Francis; April M B Grudell; Tushar Dabade; Angelica Ramirez; MhdMaan Alkhatib; Jeffrey A Alexander; Jessica Kimber; Ganapathy Prasad; Alan R Zinsmeister; Yvonne Romero
Journal:  Dysphagia       Date:  2009-10-24       Impact factor: 3.438

10.  How young can children reliably and validly self-report their health-related quality of life?: an analysis of 8,591 children across age subgroups with the PedsQL 4.0 Generic Core Scales.

Authors:  James W Varni; Christine A Limbers; Tasha M Burwinkle
Journal:  Health Qual Life Outcomes       Date:  2007-01-03       Impact factor: 3.186

View more
  37 in total

1.  Alignment of parent- and child-reported outcomes and histology in eosinophilic esophagitis across multiple CEGIR sites.

Authors:  Seema S Aceves; Eileen King; Margaret H Collins; Guang-Yu Yang; Kelley E Capocelli; J Pablo Abonia; Dan Atkins; Peter A Bonis; Christina L Carpenter; Evan S Dellon; Michael D Eby; Gary W Falk; Nirmala Gonsalves; Sandeep K Gupta; Ikuo Hirano; Kendra Kocher; Jeffrey P Krischer; John Leung; Jessi Lipscomb; Paul Menard-Katcher; Vincent A Mukkada; Zhaoxing Pan; Jonathan M Spergel; Qin Sun; Barry K Wershil; Marc E Rothenberg; Glenn T Furuta
Journal:  J Allergy Clin Immunol       Date:  2018-05-29       Impact factor: 10.793

Review 2.  A Conceptual Approach to Understanding Treatment Response in Eosinophilic Esophagitis.

Authors:  Evan S Dellon; Sandeep K Gupta
Journal:  Clin Gastroenterol Hepatol       Date:  2019-01-30       Impact factor: 11.382

Review 3.  Eosinophilic esophagitis phenotypes: Ready for prime time?

Authors:  Dan Atkins; Glenn T Furuta; Chris A Liacouras; Jonathan M Spergel
Journal:  Pediatr Allergy Immunol       Date:  2017-05-04       Impact factor: 6.377

Review 4.  White Paper AGA: Drug Development for Eosinophilic Esophagitis.

Authors:  Ikuo Hirano; Stuart Spechler; Glenn Furuta; Evan S Dellon
Journal:  Clin Gastroenterol Hepatol       Date:  2017-03-22       Impact factor: 11.382

Review 5.  Remodeling and fibrosis in chronic eosinophil inflammation.

Authors:  Seema S Aceves
Journal:  Dig Dis       Date:  2014-02-28       Impact factor: 2.404

6.  Eosinophilic esophagitis: historical perspective on an evolving disease.

Authors:  Stephen E Attwood; Glenn T Furuta
Journal:  Gastroenterol Clin North Am       Date:  2014-03-24       Impact factor: 3.806

7.  PedsQL Neurofibromatosis Type 1 Module for children, adolescents and young adults: feasibility, reliability, and validity.

Authors:  Kavitha Nutakki; James W Varni; Nancy L Swigonski
Journal:  J Neurooncol       Date:  2017-12-22       Impact factor: 4.130

8.  Management of refractory eosinophilic esophagitis.

Authors:  Vincent A Mukkada; Glenn T Furuta
Journal:  Dig Dis       Date:  2014-02-28       Impact factor: 2.404

Review 9.  Unmet therapeutic needs in eosinophilic esophagitis.

Authors:  Seema S Aceves
Journal:  Dig Dis       Date:  2014-02-28       Impact factor: 2.404

10.  Cost Utility Analysis of Topical Steroids Compared With Dietary Elimination for Treatment of Eosinophilic Esophagitis.

Authors:  Cary C Cotton; Daniel Erim; Swathi Eluri; Sarah H Palmer; Daniel J Green; W Asher Wolf; Thomas M Runge; Stephanie Wheeler; Nicholas J Shaheen; Evan S Dellon
Journal:  Clin Gastroenterol Hepatol       Date:  2016-12-07       Impact factor: 11.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.